A short video on CV & CKD outcomes & subgroup analysis of Credence Trial:
https://www.healio.com/endocrinology/diabetes/news/online/%7Bf2856cfc-92c4-4318-8a2e-69ba2e8090c2%7D/video-new-credence-data-demonstrates-cv-renal-benefit-in-primary-prevention-population
This is the trial Janssen were utilising PromarkerD Test for. I think Primary prevention is a big keyword here.
Have a great day all
Ann: PromarkerD to feature at world's largest diabetes conference, page-12
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.020(6.56%) |
Mkt cap ! $49.05M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 31.0¢ | 28.5¢ | $175.8K | 590.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 88240 | 4 |
View Market Depth
| Last trade - 15.08pm 26/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |